IntraBio Inc
7 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Pivotal Study of N-acetyl-L-leucine for CACNA1A (NCT07221292) | IntraBio Inc | 2026-09-01 |
| A Pivotal Study of N-Acetyl-L-Leucine on Niemann-Pick Disease Type C (NCT05163288) | IntraBio Inc | 2022-06-30 |
| N-Acetyl-L-Leucine for Ataxia-Telangiectasia (A-T) (NCT03759678) | IntraBio Inc | 2020-01-08 |
| N-Acetyl-L-Leucine for GM2 Gangliosidosis (Tay-Sachs and Sandhoff Disease) (NCT03759665) | IntraBio Inc | 2019-06-07 |
Track IntraBio Inc automatically
Every clearance here is in the API, with alerts when new ones post.